June 22 (Reuters) - Abbvie Inc ( ABBV ):

* ABBVIE TO ACQUIRE APOGEE THERAPEUTICS, DEEPENING

IMMUNOLOGY PORTFOLIO

* ABBVIE ( ABBV ) - APOGEE SHAREHOLDERS TO RECEIVE $135.11 PER SHARE

IN CASH

* ABBVIE ( ABBV ) - DEAL VALUES APOGEE AT $10.9 BILLION EQUITY VALUE

* ABBVIE ( ABBV ) - DEAL EXPECTED TO BE ACCRETIVE TO ABBVIE'S

ADJUSTED DILUTED EPS BEGINNING IN 2032

* ABBVIE ( ABBV ) - DEAL EXPECTED TO CLOSE IN Q3 2026

Source text:

Further company coverage: